[Therapeutic drug monitoring of aripiprazole as part of the individualization of the pharmacotherapy of schizophrenia].
N V BaymeevaI I MiroshnichenkoA I PlatovaDenis V TikhonovVasily G KaledaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
The results show the significant metabolism of ARI. A combined determination of the main substance and its active metabolite DHA in the patient's blood serum is advisable for correct assessment of the TLM result in patients with mental diseases.